发明名称 Oral formulations of mitochondrially-targeted antioxidants and their preparation and use
摘要 Provided are stable liquid and solid formulations of oxidized and reduced mitochondria-targeted antioxidants, and methods of their preparation and use.
申请公布号 US9192676(B2) 申请公布日期 2015.11.24
申请号 US201214123311 申请日期 2012.06.04
申请人 MITOTECH SA 发明人 Skulachev Maxim V.;Skulachev Vladimir P.;Zamyatnin Andrey A.;Efremov Eugeny S.;Tashlitsky Vadim N.;Zinovkin Roman A.;Egorov Maxim V.;Friedhoff Lawrence T.;Pletushkina Olga Y.;Andreev-Andrievsky Alexander A.;Zinevich Tatiana V.
分类号 A61K31/66;A61K47/26;A61K31/352;A61K31/4375;C07F9/54;A61K47/10;A61K47/12;A61K9/00;A61K47/36;A61K47/14 主分类号 A61K31/66
代理机构 DLA Piper LLP (US) 代理人 Kerner Ann-Louise;DLA Piper LLP (US)
主权项 1. A pharmaceutical formulation comprising a compound of Formula I in oxidized and/or reduced form: wherein: A is an antioxidant of Formula II: and/or reduced form thereof, wherein: m comprises an integer from 1 to 3;Y is methyl; L is a linker group comprising a straight or branched hydrocarbon chain optionally substituted by one or more double or triple bond, or ether bond, or ester bond, or C—S, or S—S, or peptide bond; and which is optionally substituted by one or more substituents selected from alkyl, alkoxy, halogen, keto group, amino group; n is an integer from 1 to 20; andB is a targeting group is: a Skulachev ion Sk+Z−, wherein: Sk is a lipophilic cation or a lipophilic metalloporphyrin; andZ is a pharmaceutically acceptable anion, the compound being in about 10% to about 100% of a liquid solvent selected from the group consisting of glycol and glycerol.
地址 Luxembourg LU